000 01549 a2200421 4500
005 20250517064243.0
264 0 _c20160906
008 201609s 0 0 eng d
022 _a2296-5262
024 7 _a10.1159/000441310
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVogel, Arndt
245 0 0 _aPatients with Advanced Pancreatic Cancer and Hyperbilirubinaemia: Review and German Expert Opinion on Treatment with nab-Paclitaxel plus Gemcitabine.
_h[electronic resource]
260 _bOncology research and treatment
_c2015
300 _a596-603 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAlbumins
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aDeoxycytidine
_xadministration & dosage
650 0 4 _aEvidence-Based Medicine
650 0 4 _aGermany
650 0 4 _aHumans
650 0 4 _aHyperbilirubinemia
_xcomplications
650 0 4 _aPaclitaxel
_xadministration & dosage
650 0 4 _aPancreatic Neoplasms
_xcomplications
650 0 4 _aTreatment Outcome
650 0 4 _aGemcitabine
700 1 _aKullmann, Frank
700 1 _aKunzmann, Volker
700 1 _aAl-Batran, Salah-Eddin
700 1 _aOettle, Helmut
700 1 _aPlentz, Ruben
700 1 _aSiveke, Jens
700 1 _aSpringfeld, Christoph
700 1 _aRiess, Hanno
773 0 _tOncology research and treatment
_gvol. 38
_gno. 11
_gp. 596-603
856 4 0 _uhttps://doi.org/10.1159/000441310
_zAvailable from publisher's website
999 _c25478173
_d25478173